Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The gold rush 1925-35.

R Y Keers

    Thorax
    |December 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Gold therapy for tuberculosis, introduced in 1925 with sanocrysin, showed initial promise but high toxicity and inconsistent results led to its decline. A US trial in 1934-35 ultimately ended its widespread use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tuberculous Pyo-Pneumothorax, with Special Reference to Certain Points in Its Management.

    Edinburgh medical journal·2018
    Same author

    The clinical position with particular reference to diet.

    The Proceedings of the Nutrition Society·2010
    Same author

    Treatment of pulmonary tuberculosis in the young adult.

    The Medical press·2010
    Same author

    Our patients' food.

    NAPT bulletin·2010
    Same author

    Intestinal tuberculosis; some observations.

    The British journal of tuberculosis and diseases of the chest·2010
    Same author

    The treatment of pulmonary tuberculosis during the past 50 years.

    Edinburgh medical journal·2010
    Same journal

    Mediastinal amyloidosis mimicking advanced lung cancer.

    Thorax·2026
    Same journal

    Comparative performance of endobronchial ultrasound-guided sampling techniques in patients with mediastinal lesions: a network meta-analysis.

    Thorax·2026
    Same journal

    Vitamin A and D impact on lung function: differential or common effects across the lifespan?

    Thorax·2026
    Same journal

    The impact of vitamins A and D on lung function and regulatory epigenetics in adult and childhood asthma.

    Thorax·2026
    Same journal

    Radiological factors associated with the recurrence of <i>Mycobacterium avium complex</i> pulmonary disease: a multicentre retrospective cohort study.

    Thorax·2026
    Same journal

    Daughter vesicles in primary diaphragmatic hydatid cyst.

    Thorax·2026
    See all related articles

    Area of Science:

    • Medical History
    • Pharmacology
    • Tuberculosis Research

    Background:

    • Pulmonary tuberculosis treatment historically involved experimental approaches.
    • Gold preparations were explored for tuberculosis management since Koch's era.
    • Sanocrysin, a gold-sodium thiosulphate, emerged as a key therapeutic agent in 1925.

    Observation:

    • Sanocrysin's introduction in 1925 followed extensive animal experimentation.
    • Early clinical reports from Denmark and Britain showed encouraging results despite significant toxicity.
    • Physicians modified dosages to mitigate severe adverse reactions.

    Findings:

    • A comprehensive US clinical trial in 1934-35 yielded entirely adverse results.
    • Despite initial enthusiasm, gold therapy demonstrated a high failure rate and persistent toxicity.

    Related Experiment Videos

  • The US trial effectively ended the use of gold therapy in America.

    • Implications:

    • Gold therapy, once promising for tuberculosis, was largely abandoned by the late 1930s.
    • The cessation of gold therapy occurred despite the lack of superior alternatives at the time.
    • This historical episode highlights the challenges in developing effective and safe tuberculosis treatments.